<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H3465285B851C447BAEE4775EE4004281" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 88 IH: Medical Innovation Acceleration Act of 2025</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-01-03</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 88</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250103">January 3, 2025</action-date><action-desc><sponsor name-id="B001302">Mr. Biggs of Arizona</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.</official-title></form><legis-body id="HBFF0ABE068304505892CEDDD2FB63731" style="OLC"><section id="H7CC592F6249B443F886B42E67B523730" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Medical Innovation Acceleration Act of 2025</short-title></quote>. </text></section><section id="HD32CC5EDABAA4905BD47787E7D646146"><enum>2.</enum><header>Exempting non-invasive diagnostic devices from regulation as devices</header><text display-inline="no-display-inline">Section 201(h) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(h)</external-xref>) is amendedâ€”</text><paragraph id="HE92D4AADB84A4B83A9C5623A532FAFD1"><enum>(1)</enum><text>by striking <quote>section 520(o)</quote> and inserting the following: <quote>section 520(o) or any non-invasive diagnostic device</quote>; and</text></paragraph><paragraph id="H2CA0C9BCBBB545DEBA21C6BC9F6CE352"><enum>(2)</enum><text>by adding at the end the following: <quote>For purposes of the preceding sentence, the term <quote>non-invasive</quote> means, with respect to a diagnostic device, that the device does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.</quote>. </text></paragraph></section></legis-body></bill> 

